Praxis Precision Medicines Inc (PRAX)
55.00
+0.46
(+0.84%)
USD |
NASDAQ |
May 06, 10:09
Praxis Precision Medicines Price to Book Value: 10.45 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 10.36 |
| May 02, 2024 | 10.29 |
| May 01, 2024 | 10.48 |
| April 30, 2024 | 10.43 |
| April 29, 2024 | 10.80 |
| April 26, 2024 | 10.41 |
| April 25, 2024 | 10.05 |
| April 24, 2024 | 9.718 |
| April 23, 2024 | 9.280 |
| April 22, 2024 | 9.079 |
| April 19, 2024 | 8.910 |
| April 18, 2024 | 8.853 |
| April 17, 2024 | 9.649 |
| April 16, 2024 | 9.959 |
| April 15, 2024 | 10.14 |
| April 12, 2024 | 10.48 |
| April 11, 2024 | 10.23 |
| April 10, 2024 | 9.609 |
| April 09, 2024 | 10.02 |
| April 08, 2024 | 10.20 |
| April 05, 2024 | 9.550 |
| April 04, 2024 | 9.642 |
| April 03, 2024 | 10.07 |
| April 02, 2024 | 10.56 |
| April 01, 2024 | 11.14 |
| Date | Value |
|---|---|
| March 28, 2024 | 11.59 |
| March 27, 2024 | 11.25 |
| March 26, 2024 | 11.82 |
| March 25, 2024 | 9.596 |
| March 22, 2024 | 10.24 |
| March 21, 2024 | 9.959 |
| March 20, 2024 | 10.62 |
| March 19, 2024 | 10.21 |
| March 18, 2024 | 10.37 |
| March 15, 2024 | 10.48 |
| March 14, 2024 | 10.07 |
| March 13, 2024 | 10.49 |
| March 12, 2024 | 10.36 |
| March 11, 2024 | 10.09 |
| March 08, 2024 | 10.64 |
| March 07, 2024 | 10.72 |
| March 06, 2024 | 11.05 |
| March 05, 2024 | 10.20 |
| March 04, 2024 | 10.40 |
| March 01, 2024 | 9.413 |
| February 29, 2024 | 8.889 |
| February 28, 2024 | 8.930 |
| February 27, 2024 | 9.140 |
| February 26, 2024 | 8.891 |
| February 23, 2024 | 7.792 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4169
Minimum
Jun 09 2022
11.82
Maximum
Mar 26 2024
2.986
Average
2.273
Median
Jun 23 2023
Price to Book Value Benchmarks
| Catalyst Pharmaceuticals Inc | 4.503 |
| Regeneron Pharmaceuticals Inc | 3.890 |
| Atossa Therapeutics Inc | 2.382 |
| ADMA Biologics Inc | 11.51 |
| Viking Therapeutics Inc | 9.092 |
Price to Book Value Related Metrics
| PS Ratio | 147.88 |
| Price | 55.00 |
| Earnings Yield | -41.07% |
| Market Cap | 728.11M |